Table: Chugai Pharm -Q1 group results (IFRS)

Chugai Pharmaceutical

22/04/2021 09:00

Apr 22 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Mar 31, 2021        Mar 31, 2020     Dec 31, 2021 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              168.82              179.42                     
                   (-5.9 pct)          (+16.3 pct)                  
  Operating           63.97               72.41                     
                   (-11.7 pct)         (+57.1 pct)                  
  Pretax
  Net                 47.41               51.53                     
                   (-8.0 pct)          (+47.1 pct)                  
  EPS Basic         28.84 yen           31.37 yen                   
  EPS Diluted       28.82 yen           31.33 yen                   
  Ann Div                                                60.00 yen  
  -Q2 Div                               75.00 yen        30.00 yen  
  -Q4 Div                               30.00 yen        30.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T